Amyloid light chain (AL) amyloidosis

Clinical trials for Amyloid light chain (AL) amyloidosis explained in plain language.

Never miss a new study

Get alerted when new Amyloid light chain (AL) amyloidosis trials appear

Sign up with your email to follow new studies for Amyloid light chain (AL) amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug combo aims to tame rare heart disease

Disease control Ongoing

This phase 2 trial tests a drug combination including daratumumab for people with AL amyloidosis, a rare disease where abnormal proteins damage organs, especially the heart. The study has two groups: one gets the full combo right away, the other starts some drugs later. Researche…

Matched conditions: AMYLOID LIGHT CHAIN (AL) AMYLOIDOSIS

Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC

Amyloid light chain (AL) amyloidosis

Get alerted when new Amyloid light chain (AL) amyloidosis trials appear

New drug combo aims to tame rare heart disease